NCT04198766 2025-12-18Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)Inhibrx Biosciences, IncPhase 1/2 Active not recruiting296 enrolled
NCT05812027 2025-11-17A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid TumorsTScan Therapeutics, Inc.Active not recruiting1,150 enrolled
NCT05608876 2025-08-07A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck CancerQBiotics Group LimitedPhase 2 Active not recruiting15 enrolled
NCT04305795 2025-06-19An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid TumorsRakuten Medical, Inc.Phase 1/2 Active not recruiting23 enrolled
NCT03737734 2025-02-07Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)Alpha Tau Medical LTD.Phase NA Active not recruiting30 enrolled
NCT04660929 2024-12-18CAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsCarisma Therapeutics IncPhase 1 Active not recruiting48 enrolled